BR112014029874A2 - composições farmacêuticas tópicas de tipo emulsão o/a que contém um retinoide. - Google Patents

composições farmacêuticas tópicas de tipo emulsão o/a que contém um retinoide.

Info

Publication number
BR112014029874A2
BR112014029874A2 BR112014029874A BR112014029874A BR112014029874A2 BR 112014029874 A2 BR112014029874 A2 BR 112014029874A2 BR 112014029874 A BR112014029874 A BR 112014029874A BR 112014029874 A BR112014029874 A BR 112014029874A BR 112014029874 A2 BR112014029874 A2 BR 112014029874A2
Authority
BR
Brazil
Prior art keywords
retinoid
emulsion
pharmaceutical compositions
compositions containing
topical pharmaceutical
Prior art date
Application number
BR112014029874A
Other languages
English (en)
Other versions
BR112014029874A8 (pt
BR112014029874B1 (pt
Inventor
Duprat Agnès
Mallard Claire
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BR112014029874A2 publication Critical patent/BR112014029874A2/pt
Publication of BR112014029874A8 publication Critical patent/BR112014029874A8/pt
Publication of BR112014029874B1 publication Critical patent/BR112014029874B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4021-aryl substituted, e.g. piretanide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113Multiple emulsions, e.g. oil-in-water-in-oil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112014029874-2A 2012-06-01 2013-05-30 Composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica BR112014029874B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261654694P 2012-06-01 2012-06-01
US61/654,694 2012-06-01
FR1255091A FR2991175B1 (fr) 2012-06-01 2012-06-01 Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide
FR1255091 2012-06-01
PCT/EP2013/061199 WO2013178758A1 (fr) 2012-06-01 2013-05-30 Compositions pharmaceutiques topiques de type émulsion h/e contenant un rétinoïde

Publications (3)

Publication Number Publication Date
BR112014029874A2 true BR112014029874A2 (pt) 2017-06-27
BR112014029874A8 BR112014029874A8 (pt) 2021-08-24
BR112014029874B1 BR112014029874B1 (pt) 2022-01-18

Family

ID=46826691

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014029874-2A BR112014029874B1 (pt) 2012-06-01 2013-05-30 Composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica

Country Status (12)

Country Link
US (1) US9855244B2 (pt)
EP (1) EP2874619B1 (pt)
JP (1) JP2015518033A (pt)
KR (1) KR102118226B1 (pt)
CN (1) CN104507470B (pt)
AU (1) AU2013269581B2 (pt)
BR (1) BR112014029874B1 (pt)
CA (1) CA2875417A1 (pt)
FR (1) FR2991175B1 (pt)
MX (1) MX357704B (pt)
RU (1) RU2655305C2 (pt)
WO (1) WO2013178758A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016131041A1 (en) * 2015-02-13 2016-08-18 Peter Kennedy Topical vasodilator composition
US10478466B1 (en) 2015-02-13 2019-11-19 Peter Kennedy Topical vasodilator composition
RU2018119510A (ru) * 2015-10-30 2019-12-05 Тимбер Фармасьютикалз ЭлЭлСи Композиции изотретиноина и их применение и способы
WO2021104515A1 (zh) * 2019-11-29 2021-06-03 迪斯凯威(深圳)新药发展有限公司 一种取代的间三联苯类化合物及其药物组合物和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5690923A (en) * 1993-01-07 1997-11-25 Yamanouchi Europe B.V. Stable topical retinoid compositions
FR2709666B1 (fr) * 1993-09-07 1995-10-13 Oreal Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
FR2742677B1 (fr) * 1995-12-21 1998-01-16 Oreal Nanoparticules enrobees d'une phase lamellaire a base de tensioactif silicone et compositions les contenant
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US20040213754A1 (en) * 2000-10-02 2004-10-28 Cole Curtis A. Method for cleansing sensitive skin using an alkanolamine
US6881414B2 (en) * 2000-11-22 2005-04-19 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Mild cosmetic composition with stabilized retinoids
DK1532974T3 (da) * 2002-03-12 2009-05-11 Galderma Res & Dev Sammensætning, der omfatter 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthsyre, til behandling af dermatologiske lidelser
KR20070091613A (ko) * 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
PL1831149T3 (pl) * 2004-12-23 2012-06-29 Galderma Res & Dev Nowe ligandy, które modulują receptory RAR, i ich zastosowanie w medycynie i kosmetyce
FR2880020B1 (fr) * 2004-12-23 2007-02-16 Galderma Res & Dev NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
JP5113755B2 (ja) * 2005-09-23 2013-01-09 ディーエスエム アイピー アセッツ ビー.ブイ. ヒドロキシ脂肪酸を含む化粧品組成物
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) * 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2915682B1 (fr) * 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
RU2363461C2 (ru) * 2007-10-03 2009-08-10 Закрытое акционерное общество "Биологические исследования и системы" Фармацевтический препарат для наружного и местного применения на основе сигетина
US9387160B2 (en) * 2008-12-22 2016-07-12 Johnson & Johnson Consumer Holdings France Composition and method of treating skin conditions
US20120004200A1 (en) * 2008-12-23 2012-01-05 Galderma S.A. Topical pharmaceutical composition containing a water-sensitive active principle

Also Published As

Publication number Publication date
CA2875417A1 (fr) 2013-12-05
BR112014029874A8 (pt) 2021-08-24
MX357704B (es) 2018-07-20
RU2655305C2 (ru) 2018-05-24
KR102118226B1 (ko) 2020-06-02
CN104507470A (zh) 2015-04-08
FR2991175A1 (fr) 2013-12-06
JP2015518033A (ja) 2015-06-25
US20150148400A1 (en) 2015-05-28
BR112014029874B1 (pt) 2022-01-18
FR2991175B1 (fr) 2014-12-19
KR20150016984A (ko) 2015-02-13
CN104507470B (zh) 2018-06-26
EP2874619B1 (fr) 2023-01-04
US9855244B2 (en) 2018-01-02
WO2013178758A1 (fr) 2013-12-05
RU2014152992A (ru) 2016-07-27
MX2014014579A (es) 2015-03-03
EP2874619A1 (fr) 2015-05-27
AU2013269581A1 (en) 2014-12-18
AU2013269581B2 (en) 2018-03-01

Similar Documents

Publication Publication Date Title
IL241881B (en) Composition comprising at least two influenza a virus-neutralizing-binding molecules
BR112015001596A2 (pt) composição para o tratamento de hiperlipidemia que compreende oxintomodulina.
DK2838961T3 (da) Sammensætninger til maling
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
DK2882433T3 (da) Antimikrobielle sammensætninger omfattende glycerylnitrater
BR112014029885A2 (pt) composições tópicas, que contêm um retinoide, de tipo emulsão óleo em água
DK2897594T3 (da) Farmaceutisk sammensætning
AU352807S (en) Dispenser for curable compositions
CL2014003495A1 (es) Agentes herbicidas que contienen flufenacet.
CL2015001166A1 (es) Mezclas herbicidas que contienen auxinas
BR112014029879A2 (pt) composições tópicas em forma de gel que contêm um retinoide particular solubilizado
BR112014029874A2 (pt) composições farmacêuticas tópicas de tipo emulsão o/a que contém um retinoide.
BR302013001136S1 (pt) Configuração aplicada a dispensador de fluidos
BR112015014078A2 (pt) composição farmacêutica oftalmológica tópica que contém regorefenib
DK3441474T3 (da) Farmaceutiske sammensætninger indeholdende et muteret leukocidin e
DK2934510T3 (da) Lfa-1-inhibitorformuleringer
BR302013000270S1 (pt) Configuração aplicada a embalagem.
BR302012005282S1 (pt) Configuração aplicada a um gatilho dispensador de adesivo.
HK1204975A1 (en) Oil/water-emulsion-type topical compositions containing retinoid
UA24122S (uk) Етикетка для майонезу
DK2934147T3 (da) Sammensætninger, der omfatter en triazolforbindelse
UA27561S (uk) Етикетка для упаковки майонезу
UA27554S (uk) Етикетка для упаковки майонезу
BR302012005214S1 (pt) Configuração aplicada em embalagem blister.
UA27854S (uk) Етикетка для упаковки майонезу

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/05/2013, OBSERVADAS AS CONDICOES LEGAIS.